ROME ZACHARY (Chief Operating Officer) sold 8.0% of their position (25.59K shares) of KUVATRIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $12.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/30/2023ACC: 0001062993-23-017282
DirectorOfficer· Chief Operating Officer
Since Aug 2022
-25.59K
Net shares
Net seller
$12.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
25.59K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−12K
Price / share
$0.49
Trade value
$5.86K
% of position
3.8%
8/28/2023
319.28K→307.28K
Common Stock
Direct
Shares
−8.79K
Price / share
$0.48
Trade value
$4.26K
% of position
2.9%
8/29/2023
307.28K→298.49K
Common Stock
Direct
Shares
−4.80K
Price / share
$0.47
Trade value
$2.23K
% of position
1.6%
8/30/2023
298.49K→293.69K
Total
Net shares
−25.59K
Net value
-$12.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2023 | S · Sale | −12K | $0.49 | $5.86K | 3.8% | 319.28K | 307.28K |
| Common Stock Direct | 8/29/2023 | S · Sale | −8.79K | $0.48 | $4.26K | 2.9% | 307.28K | 298.49K |
| Common Stock Direct | 8/30/2023 | S · Sale | −4.80K | $0.47 | $2.23K | 1.6% | 298.49K | 293.69K |
| Total | −25.59K | -$12.35K | ||||||
Derivative Transactions0
No derivative transactions reported